Adaptive Biotechnologies (ADPT) Other Working Capital Changes (2018 - 2026)

Adaptive Biotechnologies has disclosed Other Working Capital Changes across 9 years of filings, most recently posting $15192.0 for Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at $15192.0, up 100.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $15192.0 (up 100.06% YoY), and the FY2025 annual result was $406973.0, down 46.83% from the prior year.
• Other Working Capital Changes came in at $15192.0 for Q1 2026 at Adaptive Biotechnologies, up from -$39.3 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $23.3 million in Q4 2023 to a low of -$55.9 million in Q4 2022.
• The 5-year median for Other Working Capital Changes is $319633.0 (2024), against an average of -$3.7 million.
• Across the five-year window, Other Working Capital Changes soared 2214.27% in 2022 and tumbled 4994.63% in 2025, its largest moves.
• Adaptive Biotechnologies' Other Working Capital Changes stood at -$55.9 million in 2022, then soared by 141.6% to $23.3 million in 2023, then plunged by 62.33% to $8.8 million in 2024, then slumped by 548.42% to -$39.3 million in 2025, then jumped by 100.04% to $15192.0 in 2026.
• The last three Other Working Capital Changes figures came in at $15192.0 (Q1 2026), -$39.3 million (Q4 2025), and $395476.0 (Q3 2025), per Business Quant data.